RxDoctor Payments Data

Ashley Iles, MD

Hospice and Palliative Medicine · Louisville, KYNPI 1902283609

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $109 and has fallen 84.9% since, to $16 in 2025.

$184in general payments, 2019–2025

Across 13 payments — averaging $14.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hologic Sales And Service, LLC$28
  • Lilly USA, LLC$27
  • Boehringer Ingelheim$24
  • Novo Nordisk$21
  • Exact Sciences$18
  • Johnson & Johnson$18
  • plus $48 from 4 others

What the payments were for

  • Food & beverage$184100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$184 in reported general payments places this provider in the 70th percentile of 23 hospice and palliative medicine providers in Kentucky.

See all hospice and palliative medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$8,452
Medicare patients
44
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide12$16,010
Albuterol Sulfate HfaAlbuterol Sulfate22$581
Atorvastatin Calcium86$552
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$522
Omeprazole26$298
Gabapentin25$266
Levothyroxine Sodium25$250
Amlodipine Besylate51$223
Losartan Potassium28$184
Rosuvastatin Calcium19$177
Pantoprazole Sodium15$170
Lisinopril22$162
Pregabalin11$147
Montelukast Sodium16$126
Metformin Hcl26$106

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$27$16,01012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 23 hospice and palliative medicine providers in Kentucky.

Other hospice and palliative medicine in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →